Clinical Trial Update: The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of dapagliflozin in combination with insulin in Japanese individuals with Type 1 Diabetes Mellitus; study completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2019-04-12